Earnings News - Candlesense

LiveOne (Nasdaq: LVO) to Announce Its First Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on August 13, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time)

LOS ANGELES, Aug. 11, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), an award-winning, creator-first, music, entertainment, and technology platform, plans to announce its operating and financial...

What technical patterns or momentum indicators are emerging following the release, and how might they influence short‑term trading strategies? Are there any risks or uncertainties highlighted in the earnings call that could impact the stock’s upside or downside potential? What is the cash flow situation, including operating cash generation and capital expenditures, and does it affect the company’s liquidity or dividend policy?

Symbol: LVO

25 days ago

Read more globenewswire

Motorcar Parts of America Reports Fiscal First Quarter Results

LOS ANGELES--(BUSINESS WIRE)--Motorcar Parts of America, Inc. (Nasdaq: MPAA) today reported results for its fiscal 2026 first quarter -- reflecting record sales and gross profit for a fiscal first ...

How will the results affect the short‑term technical outlook and trading volume for MPAA stock? What is the expected impact on the company's valuation multiples (e.g., P/E, EV/EBITDA) after this release? Are there any macro‑economic or supply‑chain risks that could impact future quarters?

Symbol: MPAA

25 days ago

Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, ...

Are there any indications of upcoming product launches or market expansions that could impact long‑term growth? What potential catalysts or risks could drive the stock price in the short term following this release? How does Protara's Q2 performance and pipeline outlook compare to its main competitors in the oncology and rare disease space?

Symbol: TARA

25 days ago

Read more globenewswire

ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025

UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced tod...

Will the Q2 results lead to any adjustments in short‑term trading strategies or position sizing for PRPH? Did the management address any macroeconomic or supply chain risks that could influence the company's outlook? What was the market's reaction to the earnings call and are there any notable shifts in institutional sentiment?

Symbol: PRPH

25 days ago

Read more globenewswire

Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress

– New Patient Screening for Phase 3 SENTRY Trial in Myelofibrosis Expected to Close This Week; Top-Line Results Anticipated in March 2026 – – Total Revenue was $37.9 Million; U.S. XPOVIO® (selinexo...

How might the trial progress and revenue trends influence short‑term technical indicators and trading volume for KPTX? What is the expected timeline for any potential regulatory submissions or approvals related to selinexor following the trial outcomes? How does Karyopharm's total revenue of $37.9 million compare with consensus estimates for Q2 2025?

Symbol: KPTX

25 days ago

Read more prnewswire

Zoomcar Set to Unveil Q1 FY 2025-26 Earnings Call: Key Updates on Growth and Market Strategy

BENGALURU, India, Aug. 11, 2025 /PRNewswire/ -- Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") (OTCQX: ZCAR), the leading marketplace for self-drive car sharing in India, plans to report its f...

How might the Q1 earnings and strategic updates affect short‑term trading volumes and price volatility for ZCAR? Will the company provide updates on key operational metrics such as fleet utilization, average daily rate, and customer acquisition cost? What are the implications of the earnings call for Zoomcar's cash conversion cycle and working capital requirements?

Symbol: ZCAR

25 days ago

Read more prnewswire

Ballard Reports Q2 2025 Results

VANCOUVER, BC, Aug. 11, 2025 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced consolidated financial results for the second quarter ended June 30, 2025. All amounts a...

Are there any risks or uncertainties disclosed that could affect the company's performance going forward? What is the status of Ballard's order backlog and how does it compare to previous quarters? How does the reported sentiment score (30) influence the market perception of the results?

Symbol: BLDP

25 days ago

Read more prnewswire

L.B. Foster Announces Strong Second Quarter Results with Organic Growth and Profitability Expansion Expected to Continue Through Balance of 2025

PITTSBURGH, Aug. 11, 2025 (GLOBE NEWSWIRE) -- L.B. Foster Company (Nasdaq: FSTR), a global technology solutions provider of products and services for the rail and infrastructure markets (the "Com...

How does the company's cash flow generation compare to its debt obligations and potential share buyback plans? What is the company's debt profile and any changes to its credit metrics after the quarter? Are there any upcoming catalyst events (e.g., product launches, regulatory approvals, major contract announcements) that could affect the stock?

Symbol: FSTR

25 days ago

Read more globenewswire

TDS reports second quarter 2025 results

CHICAGO, Aug. 11, 2025 /PRNewswire/ -- As previously announced, TDS will hold a teleconference on August 11, 2025, at 9:00 a.m. CDT. Listen to the call live via the Events & Presentations page of i...

How might the results influence the company's dividend policy or share‑buyback plans? Did the teleconference reveal any new strategic initiatives, such as network upgrades, partnerships, or acquisitions? Are there any macroeconomic or regulatory factors highlighted that could affect future performance?

Symbol: TDS

25 days ago

Read more prnewswire

Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company focused on innovation, today reports financial results for the second quarter o...

How might the Q2 results and strategic progress influence analyst sentiment and target price revisions for Agenus? What are the potential risks or uncertainties highlighted in the release that could affect the stock's short‑term volatility? How does the current cash position and financing activities support the company's runway and ability to fund ongoing clinical programs?

Symbol: AGEN

25 days ago